{"organizations": [], "uuid": "568024957e462f2c5b91ccef5646bf80b3918f79", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/idUSL8N1PX3GC", "country": "US", "domain_rank": 408, "title": "BRIEF-Bionaturis Gets Patent For BNT005 In US", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.484, "site_type": "news", "published": "2018-02-07T18:31:00.000+02:00", "replies_count": 0, "uuid": "568024957e462f2c5b91ccef5646bf80b3918f79"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/idUSL8N1PX3GC", "ord_in_thread": 0, "title": "BRIEF-Bionaturis Gets Patent For BNT005 In US", "locations": [], "entities": {"persons": [], "locations": [{"name": "us", "sentiment": "none"}, {"name": "argentina", "sentiment": "none"}], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "gdynia newsroom", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 7 (Reuters) - BIOORGANIC RESEARCH AND SERVICES SA (BIONATURIS):\n* SAYS GETS PATENT IN UNITED STATES FOR ITS MOLECULE USEFUL IN IMMUNOTHERAPY FOR CANINE LEISHMANIASIS\n* SAYS GETS 196,300 EURO GRANT TO DEVELOP THE PROJECT, TO APPLY FOR MARKETING AUTHORIZATION OF BNT005 IN ARGENTINA\nSource text: bit.ly/2sfrcCb\nFurther company coverage: (Gdynia Newsroom)\n ", "external_links": ["http://bit.ly/2sfrcCb", "http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T18:31:00.000+02:00", "crawled": "2018-02-09T05:43:19.008+02:00", "highlightTitle": ""}